Volpara takes first step towards cracking the UK health market - Stockhead

Volpara Health has entered the UK market a week after saying the British National Health Service (NHS) would be a 10-year marathon to crack.

The breast cancer detection business (ASX:VHT) is starting a two-year trial with the Manchester University NHS Foundation Trust, in a bid to get the technology into a breast screening program.

The trial, funded by the National Institute for Health Research (NIHR), will target women in Greater Manchester, East Cheshire and East Lancashire.


(If the link is not working, try the archived version.)

Published by Stockhead on 20 February 2018.